Search

everythinglearnresearchcommunity

for

Search:↓

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Nanomaterials show promise in improving wound healing but require more research on their potential toxicity.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

COVID-19 may worsen hair loss, and Nourkrin® could be a safe treatment option, but more research is needed.

Natural compounds from Chinese herbs may safely promote hair growth and treat common hair loss.

Some drugs used to treat immune conditions may cause different types of hair loss.

Stem cell therapy is promising for treating various health conditions, but more research is needed to understand its full potential and address challenges.

Tamarix aphylla may be effective for various medical conditions, but more research is needed to confirm its safety and effectiveness.

Dandruff might be caused by changes in how hair follicles naturally release oils and an immune response to this imbalance.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Immunization and throat bacteria may increase the risk of a hair loss condition called alopecia areata.

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Oxidative stress is linked to mild patchy alopecia areata.

Roxithromycin, an antibiotic, can increase hair growth and might be used as a treatment for hair loss.

People with vitiligo may have a higher rate of Helicobacter pylori infection, but the infection's severity doesn't affect how severe the vitiligo is.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

People with lichen planus are more likely to have abnormal blood fats than healthy people.

Lupus treatment requires a combination of drugs and therapies, with research needed for new options.

Iron deficiency might contribute to hair loss in women.

Blocking a specific enzyme can reduce the negative impact of stress hormones on hair growth cells.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Finasteride helps female-pattern hair loss.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

Minoxidil effectively and safely treats patchy hair loss, but more research needed.